176 related articles for article (PubMed ID: 38041121)
41. Knowledge, attitudes and acceptance toward Human papillomavirus (HPV) vaccination: Perspectives of Muslim women and men.
Al Alawi S; Al Zaabi O; Heffernan ME; Arulappan J; Al Hasani N; Al Baluchi M; Al Mamari A; Al Saadi A
Vaccine; 2023 Mar; 41(13):2224-2233. PubMed ID: 36858872
[TBL] [Abstract][Full Text] [Related]
42. Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents.
La Vincente SF; Mielnik D; Jenkins K; Bingwor F; Volavola L; Marshall H; Druavesi P; Russell FM; Lokuge K; Mulholland EK
BMC Public Health; 2015 Dec; 15():1257. PubMed ID: 26684658
[TBL] [Abstract][Full Text] [Related]
43. Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.
Amdisen L; Kristensen ML; Rytter D; Mølbak K; Valentiner-Branth P
Vaccine; 2018 Sep; 36(38):5747-5753. PubMed ID: 30111513
[TBL] [Abstract][Full Text] [Related]
44. Perception about human papillomavirus vaccination among middle adolescent school girls in Addis Ababa, Ethiopia 2023: qualitative study.
Wubu A; Balta B; Cherie A; Bizuwork K
BMC Womens Health; 2023 Sep; 23(1):520. PubMed ID: 37777713
[TBL] [Abstract][Full Text] [Related]
45. HPV vaccine hesitancy among parents in Italy: a cross-sectional study.
Della Polla G; Pelullo CP; Napolitano F; Angelillo IF
Hum Vaccin Immunother; 2020 Nov; 16(11):2744-2751. PubMed ID: 32298210
[TBL] [Abstract][Full Text] [Related]
46. Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
Garon JR; Mukavhi A; Rupfutse M; Bright S; Brennan T; Manangazira P; An Q; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A30-A37. PubMed ID: 34144852
[TBL] [Abstract][Full Text] [Related]
47. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya.
Vermandere H; Naanyu V; Mabeya H; Vanden Broeck D; Michielsen K; Degomme O
PLoS One; 2014; 9(10):e109353. PubMed ID: 25299646
[TBL] [Abstract][Full Text] [Related]
48. HPV Vaccine Hesitancy and Influencing Factors among University Students in China: A Cross-Sectional Survey Based on the 3Cs Model.
Huang Y; Chen C; Wang L; Wu H; Chen T; Zhang L
Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360905
[TBL] [Abstract][Full Text] [Related]
49. Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
Choi J; Markham C; Tamí-Maury I; Kim S; Cuccaro P
PLoS One; 2023; 18(3):e0282811. PubMed ID: 36897868
[TBL] [Abstract][Full Text] [Related]
50. Factors affecting children's HPV vaccination in Austria: Evidence from a parent survey.
Waser M; Heiss R; Borena W
Hum Vaccin Immunother; 2022 Nov; 18(6):2126251. PubMed ID: 36251011
[TBL] [Abstract][Full Text] [Related]
51. Human Papillomavirus Vaccine Acceptability among Parents of Adolescent Girls in a Rural Area, Mysore, India.
Degarege A; Krupp K; Fennie K; Srinivas V; Li T; Stephens DP; Marlow LAV; Arun A; Madhivanan P
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):583-591. PubMed ID: 30055285
[TBL] [Abstract][Full Text] [Related]
52. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
Milondzo T; Meyer JC; Dochez C; Burnett RJ
Front Public Health; 2021; 9():598625. PubMed ID: 33681125
[No Abstract] [Full Text] [Related]
53. How can we improve the acceptability of vaccination against Human Papillomavirus (HPV) in France? An original qualitative study with focus groups comprising parents and school staff, interviewed separately.
Ailloud J; Branchereau M; Fall E; Juneau C; Partouche H; Bonnay S; Oudin-Doglioni D; Michel M; Gagneux-Brunon A; Bruel S; Thilly N; Gauchet A;
Vaccine; 2023 Jul; 41(31):4594-4608. PubMed ID: 37344259
[TBL] [Abstract][Full Text] [Related]
54. Level of awareness, attitude and perception about human papilloma virus vaccine among University of Mauritius students.
Teeluck HK; Bholoa DK; Keenoo BS
Afr J Reprod Health; 2022 Dec; 26(12):41-48. PubMed ID: 37585084
[TBL] [Abstract][Full Text] [Related]
55. Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents.
Yuen WWY; Lee A; Chan PKS; Tran L; Sayko E
PLoS One; 2018; 13(3):e0194159. PubMed ID: 29543839
[TBL] [Abstract][Full Text] [Related]
56. Knowledge about HPV Infection and the HPV Vaccine among Parents in Southeastern Serbia.
Rancic NK; Miljkovic PM; Deljanin ZM; Marinkov-Zivkovic EM; Stamenkovic BN; Bojanovic MR; Jovanovic MM; Miljkovic DP; Stankovic SM; Otasevic SA
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556899
[TBL] [Abstract][Full Text] [Related]
57. Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China.
Wang W; Ma Y; Wang X; Zou H; Zhao F; Wang S; Zhang S; Zhao Y; Marley G; Ma W
Vaccine; 2015 May; 33(22):2570-6. PubMed ID: 25887088
[TBL] [Abstract][Full Text] [Related]
58. Examining multilevel influences on parental HPV vaccine hesitancy among multiethnic communities in Los Angeles: a qualitative analysis.
Shin MB; Sloan KE; Martinez B; Soto C; Baezconde-Garbanati L; Unger JB; Kast WM; Cockburn M; Tsui J
BMC Public Health; 2023 Mar; 23(1):545. PubMed ID: 36949438
[TBL] [Abstract][Full Text] [Related]
59. Characterizing U.S. mothers with high human papillomavirus vaccine intent yet unvaccinated adolescents.
Srivastava T; Head KJ; O'Dell SM; Feemster KA; Panozzo CA; Zimet GD; Kornides ML
Prev Med; 2023 Apr; 169():107472. PubMed ID: 36854366
[TBL] [Abstract][Full Text] [Related]
60. Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District, Uganda.
Kisaakye E; Namakula J; Kihembo C; Kisakye A; Nsubuga P; Babirye JN
Pan Afr Med J; 2018; 31():184. PubMed ID: 31086634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
